Search Results - "Pawarode, Attaphol"

Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT by Choi, Sung Won, Braun, Thomas, Henig, Israel, Gatza, Erin, Magenau, John, Parkin, Brian, Pawarode, Attaphol, Riwes, Mary, Yanik, Greg, Dinarello, Charles A., Reddy, Pavan

“…The oral histone deacetylase (HDAC) inhibitor (vorinostat) is safe and results in low incidence of acute graft-versus-host disease (GVHD) after…”
Get full text

Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation by Fenske, Timothy S., Ahn, Kwang W., Graff, Tara M., DiGilio, Alyssa, Bashir, Qaiser, Kamble, Rammurti T., Ayala, Ernesto, Bacher, Ulrike, Brammer, Jonathan E., Cairo, Mitchell, Chen, Andy, Chen, Yi‐Bin, Chhabra, Saurabh, D'Souza, Anita, Farooq, Umar, Freytes, Cesar, Ganguly, Siddhartha, Hertzberg, Mark, Inwards, David, Jaglowski, Samantha, Kharfan‐Dabaja, Mohamed A., Lazarus, Hillard M., Nathan, Sunita, Pawarode, Attaphol, Perales, Miguel‐Angel, Reddy, Nishitha, Seo, Sachiko, Sureda, Anna, Smith, Sonali M., Hamadani, Mehdi

“…Summary For diffuse large B‐cell lymphoma (DLBCL) patients progressing after autologous haematopoietic cell transplantation (autoHCT), allogeneic HCT (alloHCT)…”
Get full text

Is age a risk factor for cognitive changes following hematopoietic cell transplantation? by Stratton, John, Sylvia, Allison, Hoodin, Flora, Choi, Sung Won, Pawarode, Attaphol, Giordani, Bruno, Votruba, Kristen

“…Cognitive deficits following hematopoietic cell transplantation (HCT) are common and affect post-HCT treatment regimen adherence and quality-of-life. Little is…”
Get full text

Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy by Mercadal, Santiago, Ahn, Kwang Woo, Allbee-Johnson, Mariam, Ganguly, Siddhartha, Geethakumari, Praveen Ramakrishnan, Hong, Sanghee, Malone, Adriana, Murthy, Hemant, Pawarode, Attaphol, Sica, Alejandro R, Solh, Melhem, Ustun, Celalettin, Shadman, Mazyar, Sauter, Craig S, Hamadani, Mehdi, Herrera, Alex F, Lee, Catherine J

Get full text

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial by Choi, Sung Won, MD, Braun, Thomas, Prof, Chang, Lawrence, MD, Ferrara, James L M, Prof, Pawarode, Attaphol, MD, Magenau, John M, MD, Hou, Guoqing, PhD, Beumer, Jan H, PhD, Levine, John E, Prof, Goldstein, Steve, MD, Couriel, Daniel R, Prof, Stockerl-Goldstein, Keith, MD, Krijanovski, Oleg I, MD, Kitko, Carrie, MD, Yanik, Gregory A, Prof, Lehmann, Michael H, Prof, Tawara, Isao, MD, Sun, Yaping, MD, Paczesny, Sophie, MD, Mapara, Markus Y, Prof, Dinarello, Charles A, Prof, DiPersio, John F, Prof, Reddy, Pavan, Prof

“…Summary Background Acute graft-versus-host disease (GVHD) remains a barrier to more widespread application of allogeneic haemopoietic stem-cell…”
Get full text

Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin's lymphoma by Frame, David G, Geer, Marcus, Kasha, Salena, Markstrom, Denise, Scappaticci, Gianni, Feeney, Tate, Hayduk, Andrew, Mansoor, Hilary M, Oberfeld, Avery, D'Antonio, Hannah, Anand, Sarah, Choi, Sung Won, Maciejewski, John, Pawarode, Attaphol, Riwes, Mary Mansour, Tewari, Muneesh, Magenau, John, Ghosh, Monalisa

“…Lymphodepleting chemotherapy (LDC) is critical to CAR T-cell expansion and efficacy. Despite this, there is not a consensus in the literature regarding the…”
Get full text

Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE-BMT Risk Score by Vasbinder, Alexi, Catalan, Tonimarie, Anderson, Elizabeth, Chu, Catherine, Kotzin, Megan, Murphy, Danielle, Cheplowitz, Halle, Diaz, Kristen Machado, Bitterman, Brayden, Pizzo, Ian, Huang, Yiyuan, Xie, Jeffrey, Hoeger, Christopher W, Kaakati, Rayan, Berlin, Hanna P, Shadid, Husam, Perry, Daniel, Pan, Michael, Takiar, Radhika, Padalia, Kishan, Mills, Jamie, Meloche, Chelsea, Bardwell, Alina, Rochlen, Matthew, Blakely, Pennelope, Leja, Monika, Banerjee, Mousumi, Riwes, Mary, Magenau, John, Anand, Sarah, Ghosh, Monalisa, Pawarode, Attaphol, Yanik, Gregory, Nathan, Sunita, Maciejewski, John, Okwuosa, Tochukwu, Hayek, Salim S

“…Evidence guiding the pre-hematopoietic stem cell transplantation (HSCT) cardiovascular evaluation is limited. We sought to derive and validate a pre-HSCT score…”
Get full text

Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes by Harris, Andrew C, Kitko, Carrie L, Couriel, Daniel R, Braun, Thomas M, Choi, Sung W, Magenau, John, Mineishi, Shin, Pawarode, Attaphol, Yanik, Gregory, Levine, John E

“…Extramedullary relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia is a contributor to post-transplant mortality but…”
Get full text

Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis by Epperla, Narendranath, Ahn, Kwang W, Litovich, Carlos, Ahmed, Sairah, Battiwalla, Minoo, Cohen, Jonathon B, Dahi, Parastoo, Farhadfar, Nosha, Farooq, Umar, Freytes, Cesar O, Ghosh, Nilanjan, Haverkos, Bradley, Herrera, Alex, Hertzberg, Mark, Hildebrandt, Gerhard, Inwards, David, Kharfan-Dabaja, Mohamed A, Khimani, Farhad, Lazarus, Hillard, Lazaryan, Aleksandr, Lekakis, Lazaros, Murthy, Hemant, Nathan, Sunita, Nishihori, Taiga, Pawarode, Attaphol, Prestidge, Tim, Ramakrishnan, Praveen, Rezvani, Andrew R, Romee, Rizwan, Shah, Nirav N, Sureda, Ana, Fenske, Timothy S, Hamadani, Mehdi

“…There is a paucity of data on the role of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with angioimmunoblastic T-cell lymphoma (AITL)…”
Get full text

Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies by Magenau, John, Tobai, Hiromi, Pawarode, Attaphol, Braun, Thomas, Peres, Edward, Reddy, Pavan, Kitko, Carrie, Choi, Sung, Yanik, Gregory, Frame, David, Harris, Andrew, Erba, Harry, Kujawski, Lisa, Elenitoba-Johnson, Kojo, Sanks, Jennifer, Jones, Dawn, Paczesny, Sophie, Ferrara, James, Levine, John, Mineishi, Shin

“…Patients with hematologic malignancies not in remission before allogeneic hematopoietic stem cell transplantation (HSCT) have a poor prognosis. To improve the…”
Get full text

α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease by Magenau, John M., Goldstein, Steven C., Peltier, Dan, Soiffer, Robert J., Braun, Thomas, Pawarode, Attaphol, Riwes, Mary M., Kennel, Maggi, Antin, Joseph H., Cutler, Corey S., Ho, Vincent T., Alyea, Edwin P., Parkin, Brian L., Yanik, Gregory A., Choi, Sung Won, Lewis, Eli C., Dinarello, Charles A., Koreth, John, Reddy, Pavan

“…Corticosteroid resistance after acute graft-versus-host disease (SR-aGVHD) results in high morbidity and mortality after allogeneic hematopoietic cell…”
Get full text

Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins by PAWARODE, Attaphol, SHUKLA, Suneet, MINDERMAN, Hans, FRICKE, Stacy M, PINDER, Elaine M, OLOUGHLIN, Kieran L, AMBUDKAR, Suresh V, BAER, Maria R

“…We sought to determine the effects of the immunosuppressants, cyclosporin A (CsA), tacrolimus and sirolimus, on drug transport by the ATP-binding cassette…”
Get full text

An Algorithm Combining Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Future Graft-Versus-Host Disease Following Related Donor Hematopoietic Cell Transplantation by Harris, Andrew C., Ferrara, James L.M., Braun, Thomas M., Couriel, Daniel R., Choi, Sung W., Kitko, Carrie, Goldstein, Steven, Magenau, John M., Paczesny, Sophie, Pawarode, Attaphol, Reddy, Pavan, Yanik, Gregory A., Taylor, Austin, Connelly, James, Byersdorfer, Craig A., Levine, John E.

“…Abstract ▪463▪This icon denotes a clinically relevant abstract We have recently described an algorithm combining biomarkers and clinical characteristics, such…”
Get full text

A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma by D'Souza, Anita, Hari, Parameswaran, Pasquini, Marcelo, Braun, Thomas, Johnson, Bryon, Lundy, Steven, Couriel, Daniel, Hamadani, Mehdi, Magenau, John, Dhakal, Binod, Shah, Nirav N., Riwes, Mary, Parkin, Brian, Reddy, Pavan, Pawarode, Attaphol

“…•Post-transplantation pembrolizumab therapy with or without lenalidomide was feasible for myeloma.•The study was terminated early after failing to meet its…”
Get full text

Targeting Histone Deacetylases As a New Strategy for Graft Versus Host Disease Prevention by Choi, Sung W., DiPersio, John F., Braun, Thomas M., Hou, Guoqing, Stockerl-Goldstein, Keith, Tawara, Isao, Levine, John E., Sun, Yaping, Couriel, Daniel R., Krijanovski, Oleg I., Chang, Lawrence, Magenau, John M., Pawarode, Attaphol, Kitko, Carrie, Paczesny, Sophie, Peres, Edward M., Mineishi, Shin, Yanik, Gregory A., Lehmann, Michael, Dinarello, Charles A., Ferrara, James L.M., Reddy, Pavan

“…Abstract ▪740▪This icon denotes a clinically relevant abstract Graft-versus-host disease (GVHD) precludes an effective utilization of allogeneic hematopoietic…”
Get full text

Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease by Miller, Holly K, Braun, Thomas M, Stillwell, Terri, Harris, Andrew C, Choi, Sung, Connelly, James, Couriel, Daniel, Goldstein, Steven, Kitko, Carrie L, Magenau, John, Pawarode, Attaphol, Reddy, Pavan, Riwes, Mary, Yanik, Gregory A, Levine, John E

“…Highlights • We identified the impact of infections on development of graft-versus-host disease • The study highlights risk of life-threatening and fatal…”
Get full text

Predictive Value of Bronchiolitis Obliterans Syndrome Stage 0p in Chronic Graft-versus-Host Disease of the Lung by Abedin, Sameem, Yanik, Gregory A, Braun, Thomas, Pawarode, Attaphol, Magenau, John, Goldstein, Steven C, Levine, John E, Kitko, Carrie L, Couriel, Daniel R

“…Abstract Bronchiolitis obliterans syndrome (BOS) is a significant post-transplant complication with low survival. BOS stage 0p (BOS 0p) is a parameter detected…”
Get full text

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease by Paczesny, Sophie, Braun, Thomas, Lugt, Mark Vander, Harris, Andrew, Fiema, Bryan, Hernandez, James, Choi, Sung, Kitko, Carrie, Magenau, John, Yanik, Gregory, Peres, Edward M., Pawarode, Attaphol, Mineishi, Shin, Whitfield, Joel, Jones, Dawn, Couriel, Daniel, Reddy, Pavan, Hanash, Samir, Ferrara, James L.M., Levine, John E.

“…Abstract 675 We have previously identified five biomarker proteins that have diagnostic and prognostic value for acute graft-versus-host disease (GVHD) (Blood…”
Get full text

MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD by Major-Monfried, Hannah, Renteria, Anne S., Pawarode, Attaphol, Reddy, Pavan, Ayuk, Francis, Holler, Ernst, Efebera, Yvonne A., Hogan, William J., Wölfl, Matthias, Qayed, Muna, Hexner, Elizabeth O., Wudhikarn, Kitsada, Ordemann, Rainer, Young, Rachel, Shah, Jay, Hartwell, Matthew J., Chaudhry, Mohammed S., Aziz, Mina, Etra, Aaron, Yanik, Gregory A., Kröger, Nicolaus, Weber, Daniela, Chen, Yi-Bin, Nakamura, Ryotaro, Rösler, Wolf, Kitko, Carrie L., Harris, Andrew C., Pulsipher, Michael, Reshef, Ran, Kowalyk, Steven, Morales, George, Torres, Ivan, Özbek, Umut, Ferrara, James L.M., Levine, John E.

“…Acute graft-versus-host disease (GVHD) is treated with systemic corticosteroid immunosuppression. Clinical response after 1 week of therapy often guides…”
Get full text

Correction: Is age a risk factor for cognitive changes following hematopoietic cell transplantation? by Stratton, John, Sylvia, Allison, Hoodin, Flora, Choi, Sung Won, Pawarode, Attaphol, Giordani, Bruno, Votruba, Kristen

“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text